MOTS-c is a mitochondrial-derived peptide that has caught the attention of people interested in longevity, fat loss, blood sugar control and endurance. What makes it unusual is where it comes from: it is coded by the small genome inside mitochondria, the cell's energy factories, rather than by the DNA in the cell nucleus.
In this guide, you'll learn:
-
What MOTS-c is and how it works
-
What research shows for insulin sensitivity, body fat, endurance and aging
-
What is known about dosing and timing
-
How it compares with peptides like CJC-1295 and BPC-157
-
What is known about combining it with other compounds
-
Side effects, legal status and anti-doping rules
-
Common beginner misconceptions
One point up front: almost all MOTS-c research is in mice and cells. The only human drug trial tested a modified version, CB4211, for four weeks.
What Is MOTS-c and How Does It Work?
MOTS-c stands for Mitochondrial Open reading frame of the Twelve S rRNA type-c. It is a 16-amino-acid peptide (Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg) coded within the mitochondrial 12S rRNA gene. It was described by Changhan David Lee and colleagues at the University of Southern California in a 2015 Cell Metabolism paper.
A Signal From the Mitochondria
Mitochondria were long thought to code for only a fixed set of energy-producing proteins. MOTS-c showed they can also send signals to the rest of the body.
Its best-understood action works like this:
-
MOTS-c inhibits part of the folate cycle inside cells.
-
That causes a buildup of AICAR, a natural metabolite.
-
AICAR switches on AMPK, the cell's main energy sensor.
-
AMPK increases glucose uptake and fat burning and dials down energy-hungry processes, much as exercise does.
Under metabolic stress, MOTS-c can also move into the cell nucleus and help switch on genes involved in antioxidant defense.
Natural Levels and Exercise
The body makes MOTS-c on its own. Levels rise in muscle and blood during exercise, and some studies link lower levels with older age and poorer metabolic health. Interest in taking MOTS-c comes from the idea of reproducing those exercise-linked signals. That has not been tested in humans.
Potential Benefits of MOTS-c
The findings below come from animal and cell research unless noted.
Insulin Sensitivity and Blood Sugar
In the 2015 study, MOTS-c increased glucose uptake into skeletal muscle and improved insulin sensitivity in mice. It also prevented the insulin resistance that normally comes with a high-fat diet and with aging in mice. In the human CB4211 trial, the analog lowered blood glucose compared with placebo over four weeks.
Body Fat
Mice given MOTS-c on a high-fat diet gained less weight and less fat than untreated mice. The CB4211 trial targeted people with obesity and fatty liver and reported drops in the liver enzymes ALT and AST. Whether MOTS-c reduces fat while preserving muscle in humans has not been tested.
Endurance and Physical Capacity
A 2021 study in Nature Communications found MOTS-c improved running capacity and muscle function in young, middle-aged and old mice, and that exercise raises natural MOTS-c levels in humans. That is the source of its "exercise mimetic" label.
Aging and Stress Resistance
In mice, MOTS-c improved several markers of physical decline with age. Its role in the nucleus during stress has led researchers to describe it as a mitochondrial stress signal. Whether it affects aging in humans is unknown.
Bone
Rodent studies report protective effects on bone, which is why osteoporosis was one of the nominated uses in the FDA's 2026 review.
How MOTS-c Compares With Other Peptides
| MOTS-c | CJC-1295 / ipamorelin | BPC-157 | |
|---|---|---|---|
| Main target | Cell metabolism via AMPK | Growth hormone release | Tissue repair |
| Proposed benefits | Insulin sensitivity, fat metabolism, endurance | Growth hormone and IGF-1 levels | Tendon, ligament and gut healing |
| Builds muscle directly | No | Indirectly, via GH | No |
| Human data | One analog trial (CB4211) | Limited | 3 small pilot studies |
Combining MOTS-c With Other Compounds
No clinical trial has tested MOTS-c together with any other peptide or supplement.
Other Peptides
Online discussions often pair MOTS-c with growth hormone peptides such as CJC-1295 and ipamorelin for body composition, or with BPC-157 for recovery. These combinations are untested, and their combined effects on blood sugar and hormones are unknown.
Lifestyle and Nutrition
The strongest evidence for the outcomes people want from MOTS-c comes from things that also raise natural MOTS-c:
-
Exercise: both aerobic and resistance training improve insulin sensitivity and mitochondrial function.
-
Protein intake: adequate protein helps preserve muscle during fat loss.
-
Sleep and recovery: poor sleep worsens insulin sensitivity.
Side Effects and Safety
What Is Known
-
CB4211 trial: met its safety and tolerability goals but had injection-site reactions, which the company described as a challenge.
-
Animal studies: have not shown serious toxicity at studied doses.
-
Human data for MOTS-c itself: essentially none.
Possible Concerns
-
Injection-site reactions: redness, swelling or irritation.
-
Low blood sugar: because MOTS-c improves glucose uptake, it could add to the effect of diabetes medications such as insulin or sulfonylureas. People on these drugs should not use it without medical supervision.
-
Unknown long-term effects: on metabolism, the heart and other organs.
-
Product quality: research-grade products vary in purity and content.
It has not been studied in pregnancy, breastfeeding or people with cancer, and those groups should avoid it.
Legal Status and Anti-Doping Rules
United States
-
MOTS-c is not approved by the FDA.
-
April 2026: removed from the FDA's Category 2 list after its nomination was withdrawn.
-
July 23, 2026: the FDA's compounding advisory committee recommended adding MOTS-c to the list compounding pharmacies may use, for obesity and osteoporosis.
-
The vote is advisory. Compounding is not permitted until the FDA completes formal rulemaking.
Anti-Doping
MOTS-c is not approved for therapeutic use in any country, so it falls under the World Anti-Doping Code's S0 category for non-approved substances, banned at all times. Its effects on AMPK also overlap with the code's metabolic modulators category.
Elsewhere
MOTS-c is not approved as a medicine in Canada, the UK, the EU or Australia. Rules on import and sale of research peptides vary by country.
Common Beginner Misconceptions
"It replaces exercise"
The "exercise mimetic" label comes from mouse studies. Exercise itself has far stronger evidence and raises your own MOTS-c.
"It builds muscle"
MOTS-c acts on metabolism and endurance, not muscle growth. It is not comparable to IGF-1 or anabolic compounds.
"Natural means safe"
The body makes MOTS-c in small amounts. Injecting it at research doses is a different exposure, and human safety data are lacking.
"It's fine with diabetes medication"
Its effects on blood sugar could add to diabetes drugs. Anyone on those medications needs medical supervision.
Conclusion: Where MOTS-c Stands
MOTS-c is one of the most intriguing discoveries in metabolic research: a peptide made by mitochondria that tells the body to burn fuel more efficiently. In mice, it improved insulin sensitivity, protected against diet-driven weight gain and improved physical performance, including in old age.
The gap is human evidence. One four-week trial of a modified analog is all that exists so far. The July 2026 FDA advisory vote may create a regulated path in the US, but questions about dose, benefit and long-term safety in people remain open.
Why people are interested:
-
Better blood sugar control
-
Less fat gain on a poor diet, in animal studies
-
Improved endurance and physical function with age, in animal studies
-
A metabolic rather than hormonal mechanism
For now, exercise, diet and sleep remain the best-proven ways to get the effects MOTS-c is studied for.
Disclaimer
This article is for educational and informational purposes only. MOTS-c is not approved by the FDA or any regulatory body. Doses described come from published research and are not recommendations for use. Nothing here is medical advice. The Peptide Library is operated in connection with ZenoPeps. Research products are not intended for human consumption.
References
-
Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 2015.
-
Reddy Reynolds J, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 2021.
-
FDA advisory committee vote coverage, July 2026.